Sample | Gender | Age (years) | Clinical conditionsa | Antimicrobialb therapy |
D17 | female | 64 | hepatitis C, pulmonary emphysema | MEM, MOX, FEP, MTZ, CIP, TBZ |
D1 | female | 68 | SH, DM, hemorrhagic EVA | TEC, IPM, VAN, RIF, TZP, FLC, MTZ, AMC |
D33 | female | 72 | Guillain-Barre syndrome | ND* |
D11 | female | 73 | ARDS, collagenosis | LVX, VAN, TZP, AMK, CLR, CIP |
D9 | female | 91 | UGIB, DVT, SH, Alzheimer | CIP, MEM, LZD |
D6 | male | 84 | sepsis of pulmonary origin, CAD, heart insufficiency | CIP, TZP, TEC, MEM, VAN, CXM, AMK, MTZ |
D4 | male | 88 | EVA, ARDS, CAD | IPM, TZP, FLC, CFG, AMK |
D7 | male | 91 | ARDS, DM, SH | MTZ, LZD, IPM, CLR, AMC, TZP |
D10 | male | 94 | ARDS, chronic respiratory insufficiency, dementia | MEM, TEC, LVX, LZD, ETP |
D5 | male | 98 | ARDS, prostate tumor, bladder neoplasm | TZP, MTZ, TEC |
S1 | female | 62 | - | - |
S2 | female | 86 | - | - |
S3 | male | 61 | - | - |
S4 | female | 89 | - | - |
S5 | female | 83 | - | - |
S6 | male | 67 | - | - |
S7 | male | 74 | - | - |
S8 | male | 67 | - | - |
S9 | male | 61 | - | - |
S10 | female | 73 | - | - |